Home Overview Press Room Blog Publications For Students about us

Biotech & Pharma : Displaying 744-753 of 2122

After 23andMe, Another Personal Genetics Firm Is Charged with False Advertisingby Dina Fine MaronScientific AmericanJanuary 11th, 2014The Federal Trade Commission says GeneLink, which served 30,000 customers, made claims not based on science and failed to protect consumer information.
Chinese Scientists, “Genius Genes,” and the Future of Genomicsby Jessica CussinsBiopolitical TimesJanuary 7th, 2014The New Yorker delves into the “biological data mill” that is BGI: the world’s largest, and arguably most controversial, genomics headquarters.
Leaked Files Slam Stem-Cell Therapyby Alison AbbottNatureJanuary 7th, 2014Disclosures and resignations reveal scientific concerns over stem cell treatments conducted by Italy’s Stamina Foundation.
Claims of Stem Cell Cures by Clinic Chain, Stem.MDby Paul KnoepflerKnoepfler Lab Stem Cell BlogJanuary 6th, 2014One of the most concerning new trends in the stem cell arena is the explosive growth of chains of for-profit stem cell clinics in the US.
Should Persons Affected by Mitochondrial Disorders Not be Brought Into Existence?by Professor Calum MacKellarBioNewsJanuary 6th, 2014What is being proposed is not a form of therapy in which a person is being treated or cured for a disorder. Instead, it is making sure that certain persons are not brought into existence.
Gene Patent Case Fuels U.S. Court Test of Stem Cell Rightby Susan DeckerBloombergJanuary 5th, 2014As scientists get closer to using embryonic stem cells in new treatments for blindness, spinal cord injuries and heart disease, a U.S. legal debate could determine who profits from that research.
Genetic Testing Sparks Ethics Debate[With CGS's Marcy Darnovsky]CCTV AmericaJanuary 5th, 2014Mark Niu reports on the ethical debate surrounding genetic testing and the FDA's ruling on 23andMe.
FDA Meeting on Mitochondrial Replacement Rescheduledby Jessica CussinsBiopolitical TimesJanuary 3rd, 2014The FDA public meeting to discuss “oocyte modification in assisted reproduction” that was postponed due to the government shutdown in October has now been rescheduled for February 25-26.
New Finding Has Major Implications for Genetic Testing as Researchers Learn that Greater Numbers of Humans Have Multiple Personal Genomes by Pamela SchererDark DailyDecember 30th, 2013New insights about personal genomes will give pathologists and clinical laboratory scientists different ways to use genetic tests in the screening, diagnosis, and treatment of disease.
An Ethics for the Future of Genetic Testingby Sara HendrenThe AtlanticDecember 30th, 2013As testing becomes more advanced, how should expecting parents weigh the information they have about a fetus with the information they don't?
Displaying 744-753 of 2122  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760